Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.75 -0.23 (-2.56%)
At close: Oct 23, 2026 · 4:00 PM EDT

Aspire Biopharma Holdings (ASBP) Short-Term Debt issuances (2021)

Updated

Analysis

Aspire Biopharma Holdings (ASBP) Short-Term Debt issuances (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 2.28 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn -
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn -
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn -
10 Aspire-Lakewood Holdings 65.71 Mn 44.73 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 165,955.00
API Access

Aspire Biopharma Holdings Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=ASBP&period=max&api_key=YOUR_API_KEY